PPME1

PPME1

Target · Protein phosphatase methylesterase

PPME1 Protein phosphatase methylesterase 1 · PME-1

PPME1 (protein phosphatase methylesterase 1, also known as PME-1 or ABDH19) is a methylesterase that removes reversible carboxymethyl groups from proteins. Its best-characterised substrate is the catalytic subunit of protein phosphatase 2A (PP2A). Browse Assay Genie's current range of PPME1 research reagents below, or read on for the biology behind the target.

Nuclear localisationPP2A methylesteraseLinked to glioma progression
386 aa
Protein length
~42 kDa
Molecular weight
11q13.4
Gene locus
EC 3.1.1.89
Enzyme class
Target information

What is PPME1 (protein phosphatase methylesterase 1)?

PPME1 demethylates proteins that have been reversibly carboxymethylated. Its characterised targets are the protein phosphatase 2A catalytic subunits: UniProt reports that it demethylates PPP2CA and, in vitro, PPP2CB. Binding to PPP2CA displaces the manganese ion from the active site and inactivates the enzyme, so PPME1 acts on PP2A both as a methylesterase and as an inhibitory binding partner.

The PPME1 gene encodes a protein that belongs to the AB hydrolase superfamily. HGNC places it in two gene groups: the abhydrolase domain containing family and the protein phosphatase 2 modulatory subunits. This fits the ABDH19 alias, and the enzyme is classified as EC 3.1.1.89. According to NCBI Gene, the encoded protein is localised to the nucleus, and alternative splicing produces multiple transcript variants. The mouse and rat orthologs are both named Ppme1.

NCBI Gene summary notes that the protein supports the ERK pathway through dephosphorylation of regulatory proteins, and that it plays a role in malignant glioma progression. These links make PPME1 a useful target for studying how PP2A activity is controlled by reversible methylation. Researchers working with PPME1 may use PPME1 antibody or PPME1 ELISA kit approaches to follow expression and pathway status in model systems.

PP2A regulation

PPME1 demethylates the PP2A catalytic subunit and displaces its manganese ion on binding, making it a key factor in studying how PP2A is controlled.

Reversible protein methylation

As a carboxymethyl esterase, PPME1 is a model enzyme for studying how reversible carboxymethylation of proteins is reversed.

ERK pathway signalling

PPME1 supports the ERK pathway through dephosphorylation of regulatory proteins, which is relevant to phosphatase-dependent signalling studies.

Glioma research

PPME1 has been implicated in malignant glioma progression, giving cancer researchers a phosphatase-regulating enzyme to investigate.

Background

PPME1 frequently asked questions

What does PPME1 do?

PPME1 is a methylesterase that demethylates proteins carrying reversible carboxymethyl groups. It acts on the PP2A catalytic subunit PPP2CA and, in vitro, PPP2CB. Binding to PPP2CA displaces the manganese ion and inactivates the enzyme. NCBI Gene also links it to ERK pathway support.

What other names is PPME1 known by?

The approved HGNC name is protein phosphatase methylesterase 1, and the gene symbol is PPME1. Aliases are PME-1 and ABDH19. The ABDH19 name reflects its place in the abhydrolase domain containing group. NCBI Gene reports that alternative splicing gives multiple transcript variants.

Is PPME1 linked to disease or conserved in other species?

NCBI Gene states that PPME1 plays a role in malignant glioma progression. The gene has orthologs named Ppme1 in both mouse and rat, so rodent models can be used to study it. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other PP2A subunits, protein methylation enzymes and ERK pathway components that relate to PPME1 biology.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y570; product specifications from Assay Genie datasheets.

PPME1 Product listing